Worldwide Reports
Treatment of Excessive Bleeding in Jehovah's Witness Patients after Cardiac Surgery with Recombinant Factor VIIa (NovoSeven®)
Tanaka KA | Anesthesiology | Jan 1, 2003
Emory Healthcare
Atlanta, GA, USA
en.labelReadArticle
Abstract
Not available
We offer free consulting services for administrators and physician leaders wishing to establish a bloodless medicine and surgery program.
Interested in starting a bloodless program?
Learn how you can implement a bloodless program in your institution.
Are you a patient?
Learn more about bloodless medicine and surgery.
